Keyword search
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (3)
All (3) ((3 results))
- Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13 - 2. Cancer incidence in Canada (1992-2002) ArchivedTable: 84-601-X20040017834Description:
The annual Cancer Incidence in Canada tables provide information on the number of new cases and rates of cancer tumours and patients from 1992 onwards by five-year age-groups and sex for all Canadian provinces and territories as well as information on the primary ICD-O-3 sites of cancer.
Release date: 2004-05-06 - Articles and reports: 82-003-X20030026811Geography: CanadaDescription:
Five-year relative survival ratios for prostate and breast cancer rose substantially in the 1985 to 1987 and the 1992 to 1994 periods. Increases in survival ratios for colorectal cancer over the same periods were smaller, but still statistically significant. Relative survival for lung cancer changed little.
Release date: 2004-03-29
Data (1)
Data (1) ((1 result))
- 1. Cancer incidence in Canada (1992-2002) ArchivedTable: 84-601-X20040017834Description:
The annual Cancer Incidence in Canada tables provide information on the number of new cases and rates of cancer tumours and patients from 1992 onwards by five-year age-groups and sex for all Canadian provinces and territories as well as information on the primary ICD-O-3 sites of cancer.
Release date: 2004-05-06
Analysis (2)
Analysis (2) ((2 results))
- Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13 - Articles and reports: 82-003-X20030026811Geography: CanadaDescription:
Five-year relative survival ratios for prostate and breast cancer rose substantially in the 1985 to 1987 and the 1992 to 1994 periods. Increases in survival ratios for colorectal cancer over the same periods were smaller, but still statistically significant. Relative survival for lung cancer changed little.
Release date: 2004-03-29
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: